Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

Therapeutics

Life Sciences

Health Care

Biotechnology

Crossbow Therapeutics, Inc

Crossbow Therapeutics, Inc's headquarters in Cambridge, MA, United States

Briggs Morrison

Dmitri Wiederschain

Amanda Mak

The Scientific Research and Development team at Crossbow Therapeutics, Inc., spearheads the discovery, engineering, and development of T-Bolt™ therapies. They focus on advancing T-cell receptor-mimetic antibodies to precisely target and treat various cancers. This team plays a critical role in the innovation and optimization of immunotherapies, ensuring they are effective and scalable for clinical use.

Scientific Research and Development

The Leadership Team at Crossbow Therapeutics, Inc. is responsible for steering the strategic vision and operations of the company. Comprised of key executives such as the CEO, Chief Scientific Officer, and Senior Vice Presidents, this team ensures the effective development and deployment of the company’s cutting-edge T-Bolt™ therapies, manages high-level research and product discovery, and oversees the translation of scientific breakthroughs into actionable cancer treatments.

Crossbow Therapeutics, Inc

Org chart

Teams

Scientific Research and Development

Leadership Team

Offices

Crossbow Therapeutics, Inc

Org chart

Teams

Scientific Research and Development

Leadership Team

Offices

Related companies